Bottom line
What is HHCAX's expense ratio?
HHCAX's expense ratio is 2.11%, or about $211 a year on every $10,000 invested. That is more expensive than 76% of alternatives funds we track (median 1.54%). This share class also charges a front-end sales load of up to 5.5%, taken from your investment when you buy. Its expense ratio includes a 0.35% 12b-1 marketing fee.
Updated Oct 28, 2026
HHCAX fee table
| Net expense ratio | 2.11% |
|---|---|
| Gross expense ratio | 2.45% |
| Management fee | 1% |
| 12b-1 (distribution) fee | 0.35% |
| Other expenses | 1.07% |
| Acquired fund fees | 0.03% |
| Fee waiver / reimbursement | -0.34% |
| Max front-end sales load | 5.5% |
| Max deferred sales charge | 1% |
| Redemption fee | 0% |
Source: Fund prospectus fee table, filed Oct 28, 2026
What HHCAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| HHCAX | $752 | $1,241 | $1,755 | $3,159 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 2.11% expense ratio costs roughly $106,200 in lost growth, versus about $81,400 for the median alternatives fund (1.54%).